Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio cholerae

References

• Walker CL, Aryee MJ, Boschi-Pinto C, Black RE. Estimating diarrhea mortality among young children in low and middle income countries. PLoS One 2012; 7:e29151; PMID:22235266; http://dx.doi.org/10.1371/journal.pone.0029151
   PubMed Web of Science ®Google Scholar
• Walker CLF, Rudan I, Liu L, Nair H, Theodoratou E, Bhutta ZA, O'Brien KL, Campbell H, Black RE. Global burden of childhood pneumonia and diarrhoea. Lancet 2013; 381:1405-16; PMID:23582727; http://dx.doi.org/10.1016/S0140-6736(13)60222-6
   PubMed Web of Science ®Google Scholar
• Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, Rudan I, Campbell H, Cibulskis R, Li M., et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 2012; 379:2151-61; PMID:22579125; http://dx.doi.org/10.1016/S0140-6736(12)60560-1
   PubMed Web of Science ®Google Scholar
• O'Ryan GM, Ashkenazi-Hoffnung L, O'Ryan-Soriano MA, Ashkenazi S. Management of acute infectious diarrhea for children living in resource-limited settings. Expert Rev Anti Infect Ther 2014; 12:621-32; PMID:24661314; http://dx.doi.org/10.1586/14787210.2014.901168
   PubMedGoogle Scholar
• Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, Wu Y, Sow SO, Sur D, Breiman RF., et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the global enteric multicenter study, GEMS): a prospective, case-control study. Lancet 2013; 382:209-22; PMID:23680352; http://dx.doi.org/10.1016/S0140-6736(13)60844-2
   PubMed Web of Science ®Google Scholar
• Moyo SJ, Gro N, Matee MI, Kitundu J, Myrmel H, Mylvaganam H, Maselle SY, Langeland N. Age specific aetiological agents of diarrhoea in hospitalized children aged less than five years in dar es salaam, tanzania. BMC pediatr 2011; 11:19; PMID:21345186; http://dx.doi.org/10.1186/1471-2431-11-19
   PubMed Web of Science ®Google Scholar
• Razafindratsimandresy R, Heraud JM, Ramarokoto CE, Rabemanantsoa S, Randremanana R, Andriamamonjy NS, Richard V, Reynes JM. Rotavirus genotypes in children in the community with diarrhea in Madagascar. J Med Virol 2013; 85:1652-6; PMID:23797859; http://dx.doi.org/10.1002/jmv.23631
   PubMedGoogle Scholar
• Opintan JA, Newman MJ, Ayeh-Kumi PF, Affrim R, Gepi-Attee R, Sevilleja JE, Roche JK, Nataro JP, Warren CA, Guerrant RL. Pediatric diarrhea in southern ghana: etiology and association with intestinal inflammation and malnutrition. Am J Trop Med Hyg 2010; 83:936-43; PMID:20889896; http://dx.doi.org/10.4269/ajtmh.2010.09-0792
   PubMed Web of Science ®Google Scholar
• Ciarlet M, Schodel F. Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, rotaTeq. Vaccine 2009; 27:6:G72-81; PMID:20006144; http://dx.doi.org/10.1016/j.vaccine.2009.09.107
   PubMedGoogle Scholar
• Giaquinto C, Dominiak-Felden G, Van Damme P, Myint TT, Maldonado YA, Spoulou V, Mast TC, Staat MA. Summary of effectiveness and impact of rotavirus vaccination with the oral pentavalent rotavirus vaccine: a systematic review of the experience in industrialized countries. Hum Vaccin 2011; 7:734-48; PMID:21734466; http://dx.doi.org/10.4161/hv.7.7.15511
   PubMed Web of Science ®Google Scholar
• O'Ryan M. Rotarix TM. (RIX4414): an oral human rotavirus vaccine. Expert Rev Vaccines 2007; 6:11-9; PMID:17280473; http://dx.doi.org/10.1586/14760584.6.1.11
   PubMed Web of Science ®Google Scholar
• O'Ryan M, Linhares AC. Update on rotarix (TM): an oral human rotavirus vaccine. Expert Rev Vaccines 2009; 8:1627-41; PMID:19943758; http://dx.doi.org/10.1586/erv.09.136
   PubMed Web of Science ®Google Scholar
• O'Ryan M, Lucero Y, Linhares AC. Rotarix (R): vaccine performance 6 years postlicensure. Expert Rev Vaccines 2011; 10:1645-59; PMID:22085167; http://dx.doi.org/10.1586/erv.11.152
   PubMed Web of Science ®Google Scholar
• Soares-Weiser K, Maclehose H, Bergman H, Ben-Aharon I, Nagpal S, Goldberg E, Pitan F, Cunliffe N. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev 2012; 11:CD008521; PMID:23152260; http://dx.doi.org/10.1002/14651858.CD008521.pub3
   PubMed Web of Science ®Google Scholar
• Yen C, Tate JE, Hyde TB, Cortese MM, Lopman BA, Jiang B, Glass RI, Parashar UD. Rotavirus vaccines: current status and future considerations. Hum Vaccin Immunother 2014; 10:1436-48; PMID:24755452; http://dx.doi.org/10.4161/hv.28857
   PubMed Web of Science ®Google Scholar
• Debbink K, Lindesmith LC, Baric RS. The state of norovirus vaccines. Clin Infect Dis 2014; 58:1746-52; PMID:24585561; http://dx.doi.org/10.1093/cid/ciu120
   PubMed Web of Science ®Google Scholar
• Tan M, Jiang X. Vaccine against norovirus. Hum Vaccin Immunother 2014; 10:1449-56; PMID: 24718366; http://dx.doi.org/10.4161/hv.28626
   PubMedGoogle Scholar
• Kim YJ, Yeo SG, Park JH, Ko HJ. Shigella vaccine development: prospective animal models and current status. Curr Pharm Biotechnol 2014; 14:903-12; PMID:24372251; http://dx.doi.org/10.2174/1389201014666131226123900
   PubMedGoogle Scholar
• McLennan CA, Martin LB, Micoli F. Vaccines against invasive salmonella disease: current status and future directions. Hum Vaccin Immunother 2014; 10:1478-93; PMID:24804797; http://dx.doi.org/10.4161/hv.29054
   PubMedGoogle Scholar
• Ahmed T, Bhuiyan TR, Zaman K, Sinclair D, Qadri F. Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea. Cochrane Database Syst Rev 2013; 7:CD009029; PMID:23828581; http://dx.doi.org/10.1002/14651858.CD009029.pub2
   PubMed Web of Science ®Google Scholar
• Pastor M, Pedraz JL, Esquisabel A. The state-of-the-art of approved and under-development cholera vaccines. Vaccine 2013; 31:4069-78; PMID:23845813; http://dx.doi.org/10.1016/j.vaccine.2013.06.096
   PubMed Web of Science ®Google Scholar
• Snedeker KG, Campbell M, Sargeant JM. A systematic review of vaccinations to reduce the shedding of Escherichia coli O157 in the faeces of domestic ruminants. Zoonoses Public Health 2012; 59:126-38; PMID:21824378; http://dx.doi.org/10.1111/j.1863-2378.2011.01426.x
   PubMed Web of Science ®Google Scholar
• Varela NP, Dick P, Wilson J. Assessing the existing information on the efficacy of bovine vaccination against Escherichia coli O157:H7- a systematic review and meta-analysis. Zoonoses Public Health 2013; 60:253-68; PMID:22856462; http://dx.doi.org/10.1111/j.1863-2378.2012.01523.x
   PubMedGoogle Scholar
• de Zoete MR, van Putten JPM, Wagenaar JA. Vaccination of chickens against Campylobacter. Vaccine 2007; 25:5548-57; PMID:17224215; http://dx.doi.org/10.1016/j.vaccine.2006.12.002
   PubMed Web of Science ®Google Scholar
• Mead JR. Prospects for immunotherapy and vaccines against Cryptosporidium. Hum Vaccin Immunother 2014; 10:1505-13; PMID:24638018; http://dx.doi.org/10.4161/hv.28485
   PubMedGoogle Scholar
• Gladstone BP, Ramani S, Mukhopadhya I, Muliyil J, Sarkar R, Rehman AM, Jaffar S, Gomara MI, Gray JJ, Brown DW., et al. Protective effect of natural rotavirus infection in an Indian birth cohort. N Eng J Med 2011; 365:337-46; PMID:21793745; http://dx.doi.org/10.1056/NEJMoa1006261
   PubMed Web of Science ®Google Scholar
• Velazquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter-Campbell S, Glass RI, Estes MK, Pickering LK, Ruiz-Palacios GM. Rotavirus infections in infants as protection against subsequent infections. N Eng J Med 1996; 335:1022-8; PMID:8793926; http://dx.doi.org/10.1056/NEJM199610033351404
   PubMed Web of Science ®Google Scholar
• Parashar UD, Burton A, Lanata C, Boschi-Pinto C, Shibuya K, Steele D, Birmingham M, Glass RI. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis 2009; 200 1:S9-S15; PMID:19817620; http://dx.doi.org/10.1086/605025
   PubMedGoogle Scholar
• Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12:136-41; PMID:22030330; http://dx.doi.org/10.1016/S1473-3099(11)70253-5
   PubMed Web of Science ®Google Scholar
• Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003; 9:565-72; PMID:12737740; http://dx.doi.org/10.3201/eid0905.020562
   PubMed Web of Science ®Google Scholar
• Estes MK, Desselberger U. Rotaviruses: cause of vaccine-preventable disease yet many fundamental questions remain to be explored. Curr Opin Virol 2012; 2:369-72; PMID:22762866; http://dx.doi.org/10.1016/j.coviro.2012.06.002
   PubMedGoogle Scholar
• Greenberg HB, Estes MK. Rotaviruses: from pathogenesis to vaccination. Gastroenterology 2009; 136:1939-51; PMID:19457420; http://dx.doi.org/10.1053/j.gastro.2009.02.076
   PubMed Web of Science ®Google Scholar
• O'Ryan M. The ever-changing landscape of rotavirus serotypes. Pediatr Infect Dis J 2009; 28:S60-S2; PMID:19252426; http://dx.doi.org/10.1097/INF.0b013e3181967c29
   PubMed Web of Science ®Google Scholar
• O'Ryan ML, Hermosilla G, Osorio G. Rotavirus vaccines for the developing world. Curr Opin Infect Dis 2009; 22:483-9; PMID:19623063; http://dx.doi.org/10.1097/QCO.0b013e32833040a9
   PubMedGoogle Scholar
• O'Ryan ML, Matson DO, Estes MK, Bartlett AV, Pickering LK. Molecular epidemiology of rotavirus in children attending day care centers in Houston. J Infect Dis 1990; 162:810-6; PMID:2169496; http://dx.doi.org/10.1093/infdis/162.4.810
   PubMedGoogle Scholar
• Bernstein DI, Glass RI, Rodgers G, Davidson BL, Sack DA. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US rotavirus vaccine efficacy group. JAMA 1995; 273:1191-6; PMID:7707626; http://dx.doi.org/10.1001/jama.1995.03520390051032
   PubMed Web of Science ®Google Scholar
• Joensuu J, Koskenniemi E, Pang XL, Vesikari T. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet 1997; 350:1205-9; PMID:9652561; http://dx.doi.org/10.1016/S0140-6736(97)05118-0
   PubMed Web of Science ®Google Scholar
• Perez-Schael I, Guntinas MJ, Perez M, Pagone V, Rojas AM, Gonzalez R, Cunto W, Hoshino Y, Kapikian AZ. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N Eng J Med 1997; 337:1181-7; PMID:9337376; http://dx.doi.org/10.1056/NEJM199710233371701
   PubMed Web of Science ®Google Scholar
• Rennels MB, Glass RI, Dennehy PH, Bernstein DI, Pichichero ME, Zito ET, Mack ME, Davidson BL, Kapikian AZ. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines-report of the national multicenter trial. united states rotavirus vaccine efficacy group. Pediatrics 1996; 97:7-13; PMID:8545227
   PubMed Web of Science ®Google Scholar
• Santosham M, Moulton LH, Reid R, Croll J, Weatherholt R, Ward R, Forro J, Zito E, Mack M, Brenneman G., et al. Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in native american populations. J Pediatr 1997; 131:632-8; PMID:9386673; http://dx.doi.org/10.1016/S0022-3476(97)70076-3
   PubMed Web of Science ®Google Scholar
• Murphy TV, Gargiullo PM, Massoudi MS, Nelson DB, Jumaan AO, Okoro CA, Zanardi LR, Setia S, Fair E, LeBaron CW., et al. Rotavirus Intussusception Investigation Team. Intussusception among infants given an oral rotavirus vaccine. N Eng J Med 2001; 344:564-72; PMID:11207352; http://dx.doi.org/10.1056/NEJM200102223440804
   PubMed Web of Science ®Google Scholar
• Armah GE, Kapikian AZ, Vesikari T, Cunliffe N, Jacobson RM, Burlington DB, Ruiz LP, Jr. Efficacy, immunogenicity, and safety of two doses of a tetravalent rotavirus vaccine RRV-TV in Ghana with the first dose administered during the neonatal period. J Infect Dis 2013; 208:423-31; PMID:23599316; http://dx.doi.org/10.1093/infdis/jit174
   PubMed Web of Science ®Google Scholar
• Block SL, Vesikari T, Goveia MG, Rivers SB, Adeyi BA, Dallas MJ, Bauder J, Boslego JW, Heaton PM, Pentavalent Rotavirus Vaccine Dose Confirmation Efficacy Study G. Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf life. Pediatrics 2007; 119:11-8; PMID:17200266; http://dx.doi.org/10.1542/peds.2006-2058
   PubMed Web of Science ®Google Scholar
• Clark HF, Bernstein DI, Dennehy PH, Offit P, Pichichero M, Treanor J, Ward RL, Krah DL, Shaw A, Dallas MJ., et al.Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants. J Pediatr 2004; 144:184-90; PMID:14760258; http://dx.doi.org/10.1016/j.jpeds.2003.10.054
   PubMed Web of Science ®Google Scholar
• Vesikari T, Clark HF, Offit PA, Dallas MJ, DiStefano DJ, Goveia MG, Ward RL, Schodel F, Karvonen A, Drummond JE., et al.Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants. Vaccine 2006; 24:4821-9; PMID:16621194; http://dx.doi.org/10.1016/j.vaccine.2006.03.025
   PubMed Web of Science ®Google Scholar
• Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB., et al.Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Eng J Med 2006; 354:23-33; PMID:16394299; http://dx.doi.org/10.1056/NEJMoa052664
   PubMed Web of Science ®Google Scholar
• Tate JEPM, Cortese MM, Lopman BA, Gentsch JR, Fleming J, Steele AD, Parashar UD. Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality. Expert Rev Vaccines 2012; 11:211-20; PMID:22309669; http://dx.doi.org/10.1586/erv.11.184
   PubMed Web of Science ®Google Scholar
• Patel M, Pedreira C, De Oliveira LH, Umana J, Tate J, Lopman B, Sanchez E, Reyes M, Mercado J, Gonzalez A., et al.Duration of protection of pentavalent rotavirus vaccination in Nicaragua. Pediatrics 2012; 130:e365-72; PMID:22753550; http://dx.doi.org/10.1542/peds.2011-3478
   PubMedGoogle Scholar
• Yih WK, Lieu TA, Kulldorff M, Martin D, McMahill-Walraven CN, Platt R, Selvam N, Selvan M, Lee GM, Nguyen M. Intussusception risk after rotavirus vaccination in US infants. N Eng J Med 2014; 370:503-12; PMID:24422676; http://dx.doi.org/10.1056/NEJMoa1303164
   PubMed Web of Science ®Google Scholar
• Cunliffe NA, Witte D, Ngwira BM, Todd S, Bostock NJ, Turner AM, Chimpeni P, Victor JC, Steele AD, Bouckenooghe A., et al.Efficacy of human rotavirus vaccine against severe gastroenteritis in malawian children in the first two years of life: a randomized, double-blind, placebo controlled trial. Vaccine 2012; 30 1:A36-43; PMID:22520135; http://dx.doi.org/10.1016/j.vaccine.2011.09.120
   PubMedGoogle Scholar
• Kawamura N, Tokoeda Y, Oshima M, Okahata H, Tsutsumi H, Van Doorn LJ, Muto H, Smolenov I, Suryakiran PV, Han HH. Efficacy, safety and immunogenicity of RIX4414 in Japanese infants during the first two years of life. Vaccine 2011; 29:6335-41; PMID:21640780; http://dx.doi.org/10.1016/j.vaccine.2011.05.017
   PubMed Web of Science ®Google Scholar
• Li RC, Huang T, Li YP, Luo D, Tao J, Fu B, Si G, Nong Y, Mo ZJ, Liao XY., et al. Human rotavirus vaccine (RIX4414) efficacy in the first two years of life: a randomized, placebo-controlled trial in China. Hum Vaccin Immunother 2014; 10:11-8; PMID:24013441; http://dx.doi.org/10.4161/hv.26319
   PubMed Web of Science ®Google Scholar
• Madhi SA, Kirsten M, Louw C, Bos P, Aspinall S, Bouckenooghe A, Neuzil KM, Steele AD. Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: a randomized, double-blind, placebo-controlled trial. Vaccine 2012; 30 1:A44-51; PMID:22520136; http://dx.doi.org/10.1016/j.vaccine.2011.08.080
   PubMedGoogle Scholar
• Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor JC, Cohen R, Meurice F, Han HH, Damaso S, Bouckenooghe A. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in european infants: randomised, double-blind controlled study. Lancet 2007; 370:1757-63; PMID:18037080; http://dx.doi.org/10.1016/S0140-6736(07)61744-9
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL., et al.Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. New Engl J Med 2006; 354:11-22; PMID:16394298; http://dx.doi.org/10.1056/NEJMoa052434
   PubMed Web of Science ®Google Scholar
• Cortese MM, Immergluck LC, Held M, Jain S, Chan T, Grizas AP, Khizer S, Barrett C, Quaye O, Mijatovic-Rustempasic S., et al.Effectiveness of monovalent and pentavalent rotavirus vaccine. Pediatrics 2013; 132:e25-33; PMID:23776114; http://dx.doi.org/10.1542/peds.2012-3804
   PubMed Web of Science ®Google Scholar
• Fernandes EG, Sato HK, Leshem E, Flannery B, Konstantyner TC, Veras MA, Patel MM. Impact of rotavirus vaccination on diarrhea-related hospitalizations in Sao Paulo state, Brazil. Vaccine 2014; 32:3402-8; PMID:24736002; http://dx.doi.org/10.1016/j.vaccine.2014.04.015
   PubMed Web of Science ®Google Scholar
• Steele AD, Neuzil KM, Cunliffe NA, Madhi SA, Bos P, Ngwira B, Witte D, Todd S, Louw C, Kirsten M., et al.Human rotavirus vaccine rotarix provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial. BMC Infect Dis 2012; 12:213; PMID:22974466; http://dx.doi.org/10.1186/1471-2334-12-213
   PubMed Web of Science ®Google Scholar
• Patel MM, Lopez-Collada VR, Bulhoes MM, De Oliveira LH, Bautista Marquez A, Flannery B, Esparza-Aguilar M, Montenegro Renoiner EI, Luna-Cruz ME, Sato HK., et al.Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Eng J Med 2011; 364:2283-92; PMID:21675888; http://dx.doi.org/10.1056/NEJMoa1012952
   PubMed Web of Science ®Google Scholar
• Noel GMP, Merrot T. Intussusception risk after rotavirus vaccination in US infants. N Engl J Med 2014; 370:1766; PMID:24785219; http://dx.doi.org/10.1056/NEJMc1402790
   PubMedGoogle Scholar
• Fu C, He Q, Xu J, Xie H, Ding P, Hu W, Dong Z, Liu X, Wang M. Effectiveness of the lanzhou lamb rotavirus vaccine against gastroenteritis among children. Vaccine 2012; 31:154-8; PMID:23127516; http://dx.doi.org/10.1016/j.vaccine.2012.10.078
   PubMed Web of Science ®Google Scholar
• Dang DA, Nguyen VT, Vu DT, Nguyen TH, Nguyen DM, Yuhuan W, Baoming J, Nguyen DH, Le TL, Rotavin MVTG. A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (rotavin-M1) inVietnamese children. Vaccine 2012; 30 1:A114-21; PMID:22520120; http://dx.doi.org/10.1016/j.vaccine.2011.07.118
   PubMedGoogle Scholar
• Danchin M, Kirkwood CD, Lee KJ, Bishop RF, Watts E, Justice FA, Clifford V, Cowley D, Buttery JP, Bines JE. Phase I trial of RV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine. Vaccine 2013; 31:2610-6; PMID:23597719; http://dx.doi.org/10.1016/j.vaccine.2013.04.008
   PubMed Web of Science ®Google Scholar
• Glass RI, Bhan MK, Ray P, Bahl R, Parashar UD, Greenberg H, Rao CD, Bhandari N, Maldonado Y, Ward RL., et al.Development of candidate rotavirus vaccines derived from neonatal strains in India. J Infect Dis 2005; 192 1:S30-5; PMID:16088802; http://dx.doi.org/10.1086/431498
   PubMedGoogle Scholar
• Bhandari N, Sharma P, Taneja S, Kumar T, Rongsen-Chandola T, Appaiahgari MB, Mishra A, Singh S, Vrati S. Rotavirus Vaccine Development G. A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind, placebo-controlled trial. J Infect Dis 2009; 200:421-9; PMID:19545211; http://dx.doi.org/10.1086/600104
   PubMed Web of Science ®Google Scholar
• Luna EJ, Frazatti-Gallina NM, Timenetsky MC, Cardoso MR, Veras MA, Miraglia JL, Escobar AM, Grisi SJ, Raw I, Precioso AR. A phase I clinical trial of a new 5-valent rotavirus vaccine. Vaccine 2013; 31:1100-5; PMID:23261048; http://dx.doi.org/10.1016/j.vaccine.2012.12.020
   PubMed Web of Science ®Google Scholar
• Lappalainen S, Tamminen K, Vesikari T, Blazevic V. Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles. Hum Vaccin Immunother 2013; 9:1991-2001; PMID:23777748; http://dx.doi.org/10.4161/hv.25249
   PubMed Web of Science ®Google Scholar
• Wang L, Huang P, Fang H, Xia M, Zhong W, McNeal MM, Jiang X, Tan M. Polyvalent complexes for vaccine development. Biomaterials 2013; 34:4480-92; PMID:23498893; http://dx.doi.org/10.1016/j.biomaterials.2013.02.041
   PubMed Web of Science ®Google Scholar
• Moon S, Wang Y, Edens C, Gentsch JR, Prausnitz MR, Jiang B. Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch. Vaccine 2013; 31:3396-402; PMID:23174199; http://dx.doi.org/10.1016/j.vaccine.2012.11.027
   PubMed Web of Science ®Google Scholar
• Jiang B, Wang Y, Saluzzo JF, Bargeron K, Frachette MJ, Glass RI. Immunogenicity of a thermally inactivated rotavirus vaccine in mice. Hum Vaccin 2008; 4:143-7; PMID:18382129; http://dx.doi.org/10.4161/hv.4.2.5263
   PubMed Web of Science ®Google Scholar
• Kapikian AZ, Wyatt RG, Dolin R, Thornhill TS, Kalica AR, Chanock RM. Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis. J Virol 1972; 10:1075-81; PMID:4117963
   PubMed Web of Science ®Google Scholar
• Dolin R. Norwalk agent-like particles associated with gastroenteritis in human beings. J Am Veterinary Med Association 1978; 173:615-9; PMID:100481
   PubMed Web of Science ®Google Scholar
• Glass RI, Parashar UD, Estes MK. Norovirus gastroenteritis. N Eng J Med 2009; 361:1776-85; PMID:19864676; http://dx.doi.org/10.1056/NEJMra0804575
   PubMed Web of Science ®Google Scholar
• Green KY, Ando T, Balayan MS, Berke T, Clarke IN, Estes MK, Matson DO, Nakata S, Neill JD, Studdert MJ, et al.Taxonomy of the caliciviruses. J Infect Dis 2000; 181 2:S322-30; PMID:10804145; http://dx.doi.org/10.1086/315591
   PubMedGoogle Scholar
• Jung K, Wang Q, Kim Y, Scheuer K, Zhang Z, Shen Q, Chang KO, Saif LJ. The effects of simvastatin or interferon-α on infectivity of human norovirus using a gnotobiotic pig model for the study of antivirals. PLoS One 2012; 7:e41619; PMID:22911825; http://dx.doi.org/10.1371/journal.pone.0041619
   PubMed Web of Science ®Google Scholar
• Taube S, Kolawole AO, Hohne M, Wilkinson JE, Handley SA, Perry JW, Thackray LB, Akkina R, Wobus CE. A mouse model for human norovirus. mBio 2013; 4:e00450-13; PMID:23860770; http://dx.doi.org/10.1128/mBio.00450-13
   PubMedGoogle Scholar
• Cukor G, Blacklow NR, Echeverria P, Bedigian MK, Puruggan H, Basaca-Sevilla V. Comparative study of the acquisition of antibody to norwalk virus in pediatric populations. Infect Immun 1980; 29:822-3; PMID:7216438
   PubMed Web of Science ®Google Scholar
• Greenberg HB, Valdesuso J, Kapikian AZ, Chanock RM, Wyatt RG, Szmuness W, Larrick J, Kaplan J, Gilman RH, Sack DA. Prevalence of antibody to the norwalk virus in various countries. Infect Immun 1979; 26:270-3; PMID:227798
   PubMed Web of Science ®Google Scholar
• Greenberg HB, Valdesuso J, Yolken RH, Gangarosa E, Gary W, Wyatt RG, Konno T, Suzuki H, Chanock RM, Kapikian AZ. Role of norwalk virus in outbreaks of nonbacterial gastroenteritis. J Infect Dis 1979; 139:564-8; PMID:220341; http://dx.doi.org/10.1093/infdis/139.5.564
   PubMedGoogle Scholar
• O'Ryan ML, Mamani N, Gaggero A, Avendano LF, Prieto S, Pena A, Jiang X, Matson DO. Human caliciviruses are a significant pathogen of acute sporadic diarrhea in children of Santiago, Chile. J Infect Dis 2000; 182:1519-22; PMID:11023476; http://dx.doi.org/10.1086/315874
   PubMed Web of Science ®Google Scholar
• O'Ryan ML, Vial PA, Mamani N, Jiang X, Estes MK, Ferrecio C, Lakkis H, Matson DO. Seroprevalence of norwalk virus and mexico virus in chilean individuals: assessment of independent risk factors for antibody acquisition. Clin Infect Dis 1998; 27:789-95; PMID:9798035; http://dx.doi.org/10.1086/514949
   PubMedGoogle Scholar
• Jiang X, Wang M, Graham DY, Estes MK. Expression, self-assembly, and antigenicity of the norwalk virus capsid protein. J Virol 1992; 66:6527-32; PMID:1328679
   PubMed Web of Science ®Google Scholar
• Xi JN, Graham DY, Wang KN, Estes MK. Norwalk virus genome cloning and characterization. Science 1990; 250:1580-3; PMID:2177224; http://dx.doi.org/10.1126/science.2177224
   PubMed Web of Science ®Google Scholar
• Bucardo F, Reyes Y, Svensson L, Nordgren J. Predominance of norovirus and sapovirus in nicaragua after implementation of universal rotavirus vaccination. PLoS One 2014; 9:e98201; PMID:24849288; http://dx.doi.org/10.1371/journal.pone.0098201
   PubMed Web of Science ®Google Scholar
• Kobayashi S, Fujiwara N, Yasui Y, Yamashita T, Hiramatsu R, Minagawa H. A foodborne outbreak of sapovirus linked to catered box lunches in japan. Arch Virol 2012; 157:1995-7; PMID:22752792; http://dx.doi.org/10.1007/s00705-012-1394-8
   PubMed Web of Science ®Google Scholar
• Tam CC, O'Brien SJ, Tompkins DS, Bolton FJ, Berry L, Dodds J, Choudhury D, Halstead F, Iturriza-Gomara M, Mather K., et al.Changes in causes of acute gastroenteritis in the united kingdom over 15 years: microbiologic findings from 2 prospective, population-based studies of infectious intestinal disease. Clin Infect Dis 2012; 54:1275-86; PMID:22412058; http://dx.doi.org/10.1093/cid/cis028
   PubMedGoogle Scholar
• Ramani S, Atmar RL, Estes MK. Epidemiology of human noroviruses and updates on vaccine development. Curr Opin Gastroenterol 2014; 30:25-33; PMID:24232370http://dx.doi.org/10.1097/MOG.0000000000000022
   PubMed Web of Science ®Google Scholar
• Desai R, Hembree CD, Handel A, Matthews JE, Dickey BW, McDonald S, Hall AJ, Parashar UD, Leon JS, Lopman B. Severe outcomes are associated with genogroup 2 genotype 4 norovirus outbreaks: a systematic literature review. Clin Infect Dis 2012; 55:189-93; PMID:22491335; http://dx.doi.org/10.1093/cid/cis372
   PubMed Web of Science ®Google Scholar
• Patel MM, Hall AJ, Vinje J, Parashar UD. Noroviruses: a comprehensive review. J Clin Virol 2009; 44:1-8; PMID:19084472; http://dx.doi.org/10.1016/j.jcv.2008.10.009
   PubMed Web of Science ®Google Scholar
• Vidal R, Solari V, Mamani N, Jiang X, Vollaire J, Roessler P, Prado V, Matson DO, O'Ryan ML. Caliciviruses and foodborne gastroenteritis, Chile. Emerg Infect Dis 2005; 11:1134-7; PMID:16022799; http://dx.doi.org/10.3201/eid1107.041062
   PubMedGoogle Scholar
• Monica B, Ramani S, Banerjee I, Primrose B, Iturriza-Gomara M, Gallimore CI, Brown DW, M F, Moses PD, Gray JJ, Kang G. Human caliciviruses in symptomatic and asymptomatic infections in children in Vellore, South India. J Med Virol 2007; 79:544-51; PMID:17385696; http://dx.doi.org/10.1002/jmv.20862
   PubMedGoogle Scholar
• O'Ryan ML, Pena A, Vergara R, Diaz J, Mamani N, Cortes H, Lucero Y, Vidal R, Osorio G, Santolaya ME, Hermosilla G, Prado VJ. Prospective characterization of norovirus compared with rotavirus acute diarrhea episodes in chilean children. Pediatr Infect Dis J 2010; 29:855-9; PMID:20581736; http://dx.doi.org/10.1097/INF.0b013e3181e8b346
   PubMed Web of Science ®Google Scholar
• Patel MM, Widdowson MA, Glass RI, Akazawa K, Vinje J, Parashar UD. Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis 2008; 14:1224-31; PMID:18680645; http://dx.doi.org/10.3201/eid1408.071114
   PubMed Web of Science ®Google Scholar
• Hemming M, Rasanen S, Huhti L, Paloniemi M, Salminen M, Vesikari T. Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the national immunization programme in Finland. Eur J Pediatr 2013; 172:739-46; PMID:23361964; http://dx.doi.org/10.1007/s00431-013-1945-3
   PubMed Web of Science ®Google Scholar
• Payne DC, Vinje J, Szilagyi PG, Edwards KM, Staat MA, Weinberg GA, Hall CB, Chappell J, Bernstein DI, Curns AT., et al.Norovirus and medically attended gastroenteritis in US children. N Eng J Med 2013; 368:1121-30; PMID:23514289; http://dx.doi.org/10.1056/NEJMsa1206589
   PubMed Web of Science ®Google Scholar
• Hall AJ, Rosenthal M, Gregoricus N, Greene SA, Ferguson J, Henao OL, Vinje J, Lopman BA, Parashar UD, Widdowson MA. Incidence of acute gastroenteritis and role of norovirus, georgia, USA, 2004-2005. Emerg Infect Dis 2011; 17:1381-8; PMID:21801613; http://dx.doi.org/10.3201/eid1708.101533
   PubMed Web of Science ®Google Scholar
• Trivedi TK, Desai R, Hall AJ, Patel M, Parashar UD, Lopman BA. Clinical characteristics of norovirus-associated deaths: a systematic literature review. Am J Infect Control 2013; 41:654-7; PMID:23266383; http://dx.doi.org/10.1016/j.ajic.2012.08.002
   PubMed Web of Science ®Google Scholar
• Bok K, Green KY. Norovirus gastroenteritis in immunocompromised patients. N Eng J Med 2012; 367:2126-32; PMID:23190223; http://dx.doi.org/10.1056/NEJMra1207742
   PubMed Web of Science ®Google Scholar
• Simon A, Schildgen O, Maria Eis-Hubinger A, Hasan C, Bode U, Buderus S, Engelhart S, Fleischhack G. Norovirus outbreak in a pediatric oncology unit. Scand J Gastroenterol 2006; 41:693-9; PMID:16716968; http://dx.doi.org/10.1080/00365520500421694
   PubMed Web of Science ®Google Scholar
• Hall AJ, Lopman BA, Payne DC, Patel MM, Gastanaduy PA, Vinje J, Parashar UD. Norovirus disease in the United States. Emerg Infect Dis 2013; 19:1198-205; PMID:23876403; http://dx.doi.org/10.3201/eid1908.130465
   PubMed Web of Science ®Google Scholar
• Vidal R, Roessler P, Solari V, Vollaire J, Jiang X, Matson DO, Mamani N, Prado V, O'Ryan ML. Novel recombinant norovirus causing outbreaks of gastroenteritis in Santiago, Chile. J Clin Microbiol 2006; 44:2271-5; PMID:16757638; http://dx.doi.org/10.1128/JCM.01890-05
   PubMedGoogle Scholar
• Kroneman A, Vega E, Vennema H, Vinje J, White PA, Hansman G, Green K, Martella V, Katayama K, Koopmans M. Proposal for a unified norovirus nomenclature and genotyping. Arch Virol 2013; 158:2059-68; PMID:23615870; http://dx.doi.org/10.1007/s00705-013-1708-5
   PubMed Web of Science ®Google Scholar
• Siebenga JJ, Vennema H, Zheng DP, Vinje J, Lee BE, Pang XL, Ho ECM, Lim W, Choudekar A, Broor S., et al.Norovirus illness is a global problem: emergence and spread of norovirus GII.4 variants, 2001-2007. J Infect Dis 2009; 200:802-12; PMID:19627248; http://dx.doi.org/10.1086/605127
   PubMed Web of Science ®Google Scholar
• Parrino TA, Schreiber DS, Trier JS, Kapikian AZ, Blacklow NR. Clinical immunity in acute gastroenteritis caused by norwalk agent. N Eng J Med 1977; 297:86-9; PMID:405590; http://dx.doi.org/10.1056/NEJM197707142970204
   PubMed Web of Science ®Google Scholar
• LoBue AD, Lindesmith L, Yount B, Harrington PR, Thompson JM, Johnston RE, Moe CL, Baric RS. Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains. Vaccine 2006; 24:5220-34; PMID:16650512; http://dx.doi.org/10.1016/j.vaccine.2006.03.080
   PubMed Web of Science ®Google Scholar
• Teunis PF, Moe CL, Liu P, Miller SE, Lindesmith L, Baric RS, Le Pendu J, Calderon RL. Norwalk virus: how infectious is it? J Med Virol 2008; 80:1468-76; PMID:18551613; http://dx.doi.org/10.1002/jmv.21237
   PubMed Web of Science ®Google Scholar
• Simmons K, Gambhir M, Leon J, Lopman B. Duration of immunity to norovirus gastroenteritis. Emerg Infect Dis 2013; 19:1260-7; PMID:23876612; http://dx.doi.org/10.3201/eid1908.130472
   PubMed Web of Science ®Google Scholar
• O'Ryan ML, Lucero Y, Prado V, Santolaya ME, Rabello M, Solis Y, Berrios D, O'Ryan-Soriano MA, Cortes H, Mamani N. Symptomatic and asymptomatic rotavirus and norovirus infections during infancy in a Chilean birth cohort. Pediatr Infect Dis J 2009; 28:879-84; PMID:19672213; http://dx.doi.org/10.1097/INF.0b013e3181a4bb60
   PubMed Web of Science ®Google Scholar
• Czako R, Atmar RL, Opekun AR, Gilger MA, Graham DY, Estes MK. Serum hemagglutination inhibition activity correlates with protection from gastroenteritis in persons infected with norwalk virus. Clin Vaccine Immunol 2012; 19:284-7; PMID:22190401; http://dx.doi.org/10.1128/CVI.05592-11
   PubMedGoogle Scholar
• Reeck A, Kavanagh O, Estes MK, Opekun AR, Gilger MA, Graham DY, Atmar RL. Serological correlate of protection against norovirus-induced gastroenteritis. J Infect Dis 2010; 202:1212-8; PMID:20815703; http://dx.doi.org/10.1086/656364
   PubMed Web of Science ®Google Scholar
• Atmar RL, Bernstein DI, Harro CD, Al-Ibrahim MS, Chen WH, Ferreira J, Estes MK, Graham DY, Opekun AR, Richardson C, et al. Norovirus vaccine against experimental human norwalk virus illness. N Eng J Med 2011; 365:2178-87; PMID:22150036; http://dx.doi.org/10.1056/NEJMoa1101245
   PubMed Web of Science ®Google Scholar
• Fang H, Tan M, Xia M, Wang L, Jiang X. Norovirus P particle efficiently elicits innate, humoral and cellular immunity. PLoS One 2013; 8:e63269; PMID:23638188; http://dx.doi.org/10.1371/journal.pone.0063269
   PubMedGoogle Scholar
• LoBue AD, Thompson JM, Lindesmith L, Johnston RE, Baric RS. Alphavirus-adjuvanted norovirus-like particle vaccines: heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge. J Virol 2009; 83:3212-27; PMID:19176631; http://dx.doi.org/10.1128/JVI.01650-08
   PubMed Web of Science ®Google Scholar
• Ramirez K, Wahid R, Richardson C, Bargatze RF, El-Kamary SS, Sztein MB, Pasetti MF. Intranasal vaccination with an adjuvanted norwalk virus-like particle vaccine elicits antigen-specific B memory responses in human adult volunteers. Clin Immunol 2012; 144:98-108; PMID:22710446; http://dx.doi.org/10.1016/j.clim.2012.05.006
   PubMed Web of Science ®Google Scholar
• Tamminen K, Lappalainen S, Huhti L, Vesikari T, Blazevic V. Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice. PLoS One 2013; 8:e70409; PMID:23922988; http://dx.doi.org/10.1371/journal.pone.0070409
   PubMed Web of Science ®Google Scholar
• El-Kamary SS, Pasetti MF, Mendelman PM, Frey SE, Bernstein DI, Treanor JJ, Ferreira J, Chen WH, Sublett R, Richardson C, et al.Adjuvanted intranasal norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues. J Infect Dis 2010; 202:1649-58; PMID:20979455; http://dx.doi.org/10.1086/657087
   PubMed Web of Science ®Google Scholar
• Parra GI, Bok K, Taylor R, Haynes JR, Sosnovtsev SV, Richardson C, Green KY. Immunogenicity and specificity of norovirus consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulations. Vaccine 2012; 30:3580-6; PMID:22469864; http://dx.doi.org/10.1016/j.vaccine.2012.03.050
   PubMed Web of Science ®Google Scholar
• Treanor JJ, Atmar RL, Frey SE, Gormley R, Chen WH, Ferreira J, Goodwin R, Borkowski A, Clemens R, Mendelman PM. A novel intramuscular bivalent norovirus VLP vaccine candidate - reactogenicity, safety and immunogenicity in a phase I trial in healthy adults. J Infect Dis 2014; 210:1763-71; PMID:24951828; http://dx.doi.org/10.1093/infdis/jiu337
   PubMedGoogle Scholar
• Treanor JJ, Atmar RL, Frey SE, Gormley R, Chen WH, Ferreira J, Goodwin R, Borkowski A, Clemens R, Mendelman PM. A novel intramuscular bivalent norovirus virus-like particle vaccine candidate-reactogenicity, safety, and immunogenicity in a phase 1 trial in healthy adults. J Infect Dis 2014; 210:1763-71; PMID:24951828; http://dx.doi.org/10.1093/infdis/jiu337
   PubMedGoogle Scholar
• Tan M, Huang P, Xia M, Fang PA, Zhong W, McNeal M, Wei C, Jiang W, Jiang X. Norovirus P particle, a novel platform for vaccine development and antibody production. J Virol 2011; 85:753-64; PMID:21068235; http://dx.doi.org/10.1128/JVI.01835-10
   PubMed Web of Science ®Google Scholar
• Baric RS, Yount B, Lindesmith L, Harrington PR, Greene SR, Tseng FC, Davis N, Johnston RE, Klapper DG, Moe CL. Expression and self-assembly of norwalk virus capsid protein from venezuelan equine encephalitis virus replicons. J Virol 2002; 76:3023-30; PMID:11861868; http://dx.doi.org/10.1128/JVI.76.6.3023-3030.2002
   PubMed Web of Science ®Google Scholar
• Harris JB, LaRocque RC, Qadri F, Ryan ET, Calderwood SB. Cholera. Lancet 2012; 379:2466-76; PMID:22748592;http://dx.doi.org/10.1016/S0140-6736(12)60436-X
   PubMed Web of Science ®Google Scholar
• World Health Organization. Cholera, 2013. Wkly Epidemiol Rec 2014; 89:345-56; PMID:25136711
   PubMedGoogle Scholar
• Safa A, Nair GB, Kong RYC. Evolution of new variants of vibrio cholerae O1. Trends Microbiol 2010; 18:46-54; PMID:19942436; http://dx.doi.org/10.1016/j.tim.2009.10.003
   PubMed Web of Science ®Google Scholar
• Wang J, Villeneuve S, Zhang J, Lei P, Miller CE, Lafaye P, Nato F, Szu SC, Karpas A, Bystricky S., et al.On the antigenic determinants of the lipopolysaccharides of vibrio cholerae O1, serotypes ogawa and inaba. J Biol Chem 1998; 273:2777-83; PMID:9446585; http://dx.doi.org/10.1074/jbc.273.5.2777
   PubMed Web of Science ®Google Scholar
• Sears CL, Kaper JB. Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion. Microbiol Rev 1996; 60:167-215; PMID:8852900
   PubMedGoogle Scholar
• World Health Organization. Oral cholera vaccine stockpile for cholera emergency response. [Internet] 09/16/2013. Available from: http://www.who.int/cholera/vaccines/Briefing_OCV_stockpile.pdf?ua=1
   Google Scholar
• Chen WH, Greenberg RN, Pasetti MF, Livio S, Lock M, Gurwith M, Levine MM. Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR, prepared from new master and working cell banks. Clin Vaccine Immnunol 2014; 21:66-73; PMID:24173028; http://dx.doi.org/10.1128/CVI.00601-13
   PubMed Web of Science ®Google Scholar
• Begue RE, Castellares G, Ruiz R, Hayashi KE, Sanchez JL, Gotuzzo E, Oberst RB, Taylor DN, Svennerholm AM. Community-based assessment of safety and immunogenicity of the whole cell plus recombinant B subunit (WC/rBS) oral cholera vaccine in Peru. Vaccine 1995; 13:691-4; PMID:7668039; http://dx.doi.org/10.1016/0264-410X(94)00056-S
   PubMed Web of Science ®Google Scholar
• van Loon FP, Clemens JD, Chakraborty J, Rao MR, Kay BA, Sack DA, Yunus M, Ali M, Svennerholm AM, Holmgren J. Field trial of inactivated oral cholera vaccines in Bangladesh: results from 5 years of follow-up. Vaccine 1996; 14:162-6; PMID:8852414; http://dx.doi.org/10.1016/0264-410X(95)00122-H
   PubMed Web of Science ®Google Scholar
• Clemens JD, Sack DA, Harris JR, Chakraborty J, Khan MR, Stanton BF, Kay BA, Khan MU, Yunus M, Atkinson W, et al. Field trial of oral cholera vaccines in Bangladesh. Lancet 1986; 2:124-7; PMID:2873397; http://dx.doi.org/10.1016/S0140-6736(86)91944-6
   PubMed Web of Science ®Google Scholar
• Taylor DN, Cardenas V, Sanchez JL, Begue RE, Gilman R, Bautista C, Perez J, Puga R, Gaillour A, Meza R, et al. Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in Peru. J Infect Dis 2000; 181:1667-73; PMID:10823767; http://dx.doi.org/10.1086/315462
   PubMed Web of Science ®Google Scholar
• Mahalanabis DLA, Sur D, Deen J, Manna B, Kanungo S, von Seidlein L, Carbis R, Han SH, Shin SH, Attridge S, et al. A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India. PLoS One 2008; 3::2323; PMID:18523643; http://dx.doi.org/10.1371/journal.pone.0002323
   PubMed Web of Science ®Google Scholar
• Sur D, Kanungo S, Sah B, Manna B, Ali M, Paisley AM, Niyogi SK, Park JK, Sarkar B, Puri MK., et al.Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial. PLoS Negl Trop Dis 2011; 5:e1289; PMID:22028938; http://dx.doi.org/10.1371/journal.pntd.0001289
   PubMedGoogle Scholar
• Luquero FJGL, Ciglenecki I, Sakoba K, Traore B, Heile M, Diallo AA, Itama C, Page AL, Quilici ML, Mengel MA., et al. Use of Vibrio cholerae vaccine in an outbreak in Guinea. N Engl J Med 2014; 370:2111-20; PMID:24869721; http://dx.doi.org/10.1056/NEJMoa1312680
   PubMed Web of Science ®Google Scholar
• Anh DDCdG, Lopez AL, Thiem VD, Long PT, Son NH, Deen J, von Seidlein L, Carbis R, Han SH, Shin SH., et al.Safety and immunogenicity of a reformulated vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults. Vaccine 2007; 25:1149-55; PMID:17055622; http://dx.doi.org/10.1016/j.vaccine.2006.09.049
   PubMed Web of Science ®Google Scholar
• Anh DDLA, Thiem VD, Grahek SL, Duong TN, Park JK, Kwon HJ, Favorov M, Hien NT, Clemens JD. Use of oral cholera vaccines in an outbreak in Vietnam: a case control study. PLoS Negl Trop Dis 2011; 25:e1006; PMID:21283616; http://dx.doi.org/10.1371/journal.pntd.0001006
   PubMedGoogle Scholar
• Richie EE, Punjabi NH, Sidharta YY, Peetosutan KK, Sukandar MM, Wasserman SS, Lesmana MM, Wangsasaputra FF, Pandam SS, Levine MM., et al.Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area. Vaccine 2000; 18:2399-410; PMID:10738097; http://dx.doi.org/10.1016/S0264-410X(00)00006-2
   PubMed Web of Science ®Google Scholar
• Ali M, Emch M, von Seidlein L, Yunus M, Sack DA, Rao M, Holmgren J, Clemens JD. Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis. Lancet 2005; 366:44-9; PMID:15993232; http://dx.doi.org/10.1016/S0140-6736(05)66550-6
   PubMed Web of Science ®Google Scholar
• Sack DA, Sack RB, Shimko J, Gomes G, O'Sullivan D, Metcalfe K, Spriggs D. Evaluation of peru-15, a new live oral vaccine for cholera, in volunteers. J Infect Dis 1997; 176:201-5; PMID:9207368; http://dx.doi.org/10.1086/514025
   PubMed Web of Science ®Google Scholar
• Cohen MB, Giannella RA, Bean J, Taylor DN, Parker S, Hoeper A, Wowk S, Hawkins J, Kochi SK, Schiff G., et al.Randomized, controlled human challenge study of the safety, immunogenicity, and protective efficacy of a single dose of peru-15, a live attenuated oral cholera vaccine. Infect Immun 2002; 70:1965-70; PMID:11895960; http://dx.doi.org/10.1128/IAI.70.4.1965-1970.2002
   PubMed Web of Science ®Google Scholar
• Qadri F, Chowdhury MI, Faruque SM, Salam MA, Ahmed T, Begum YA, Saha A, Alam MS, Zaman K, Seidlein LV., et al.Randomized, controlled study of the safety and immunogenicity of peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh. J Infect Dis 2005; 192:573-9; PMID:16028125; http://dx.doi.org/10.1086/432074
   PubMed Web of Science ®Google Scholar
• Qadri F, Chowdhury MI, Faruque SM, Salam MA, Ahmed T, Begum YA, Saha A, Al Tarique A, Seidlein LV, Park E., et al.Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants. Vaccine 2007; 25:231-8; PMID:16996172; http://dx.doi.org/10.1016/j.vaccine.2006.08.031
   PubMed Web of Science ®Google Scholar
• Talavera A, Ano G, Pino Y, Castano J, Uribarri E, Riveron L, Gil S, Fernandez S, Cedre B, Valmaseda T., et al. Formulation in tablets of a cholera whole cells inactivated vaccine candidate. Vaccine 2006; 24:3381-7; PMID:16460846; http://dx.doi.org/10.1016/j.vaccine.2005.12.064
   PubMed Web of Science ®Google Scholar
• Valera R, Garcia HM, Jidy MD, Mirabal M, Armesto MI, Fando R, Garcia L, Fernandez R, Ano G, Cedre B., et al. Randomized, double-blind, placebo-controlled trial to evaluate the safety and immunogenicity of live oral cholera vaccine 638 in Cuban adults. Vaccine 2009; 27:6564-9; PMID:19720365; http://dx.doi.org/10.1016/j.vaccine.2009.08.042
   PubMed Web of Science ®Google Scholar
• Garcia L, Jidy MD, Garcia H, Rodriguez BL, Fernandez R, Ano G, Cedre B, Valmaseda T, Suzarte E, Ramirez M., et al. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers. Infect Immun 2005; 73:3018-24; PMID:15845509; http://dx.doi.org/10.1128/IAI.73.5.3018-3024.2005
   PubMed Web of Science ®Google Scholar
• Diaz Jidy M, Perez Rodriguez A, Fernandez Llanes R, Bravo Farinas L, Garcia Sanchez H, Valera Fernandez R, Garcia Imia L, Fando Calzada R, Menendez Hernandez J. Challenge clinical trial for evaluation of a vaccine candidate strain against cholera. Rev Cubana Med Trop 2010; 62:194-9; PMID:23437548
   PubMedGoogle Scholar
• Tacket CO, Losonsky G, Nataro JP, Comstock L, Michalski J, Edelman R, Kaper JB, Levine MM. Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge. J Infect Dis 1995; 172:883-6; PMID:7658089; http://dx.doi.org/10.1093/infdis/172.3.883
   PubMed Web of Science ®Google Scholar
• Mahalanabis D, Ramamurthy T, Nair GB, Ghosh A, Shaikh S, Sen B, Thungapathra M, Ghosh RK, Pazhani GP, Nandy RK., et al. Randomized placebo controlled human volunteer trial of a live oral cholera vaccine VA1.3 for safety and immune response. Vaccine 2009; 27:4850-6; PMID:19523608; http://dx.doi.org/10.1016/j.vaccine.2009.05.065
   PubMed Web of Science ®Google Scholar
• Kanungo SSB, Ramamurthy T, Sur D, Manna B, Pazhani GP, Chowdhury G, Jhunjhunwala P, Nandy RK, Koley H, Bhattacharya MK., et al.Safety and immunogenicity of a live oral recombinant cholera vaccine VA1.4: a randomized, placebo controlled trial in healthy adults in a cholera endemic area in Kolkata, India. PLoS One 2014; 9:e99381; PMID:24983989; http://dx.doi.org/10.1371/journal.pone.0099381
   PubMedGoogle Scholar
• Liang W, Wang S, Yu F, Zhang L, Qi G, Liu Y, Gao S, Kan B. Construction and evaluation of a safe, live, oral Vibrio cholerae vaccine candidate, IEM108. Infect Immun 2003; 71:5498-504; PMID:14500467; http://dx.doi.org/10.1128/IAI.71.10.5498-5504.2003
   PubMed Web of Science ®Google Scholar
• Ravichandran M, Ali SA, Rashid NHA, Kurunathan S, Yean CY, Ting LC, Bakar ASA, Lalitha P, Zainuddin ZF. Construction and evaluation of a O139 Vibrio cholerae vaccine candidate based on a hemA gene mutation. Vaccine 2006; 24:3750-61; PMID:16102875; http://dx.doi.org/10.1016/j.vaccine.2005.07.016
   PubMed Web of Science ®Google Scholar
• Ledon T, Ferran B, Perez C, Suzarte E, Vichi J, Marrero K, Oliva R, Fando R. TLP01, an mshA mutant of Vibrio cholerae O139 as vaccine candidate against cholera. Microbes Infect 2012; 14:968-78; PMID:22546527; http://dx.doi.org/10.1016/j.micinf.2012.04.004
   PubMedGoogle Scholar